KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $37.0 million.

  • Tenet Healthcare's Tax Provisions fell 5542.17% to $37.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $433.0 million, marking a year-over-year decrease of 6342.91%. This contributed to the annual value of $433.0 million for FY2025, which is 6342.91% down from last year.
  • Tenet Healthcare's Tax Provisions amounted to $37.0 million in Q4 2025, which was down 5542.17% from $133.0 million recorded in Q3 2025.
  • In the past 5 years, Tenet Healthcare's Tax Provisions ranged from a high of $750.0 million in Q1 2024 and a low of $37.0 million during Q4 2025
  • In the last 5 years, Tenet Healthcare's Tax Provisions had a median value of $92.5 million in 2022 and averaged $133.9 million.
  • As far as peak fluctuations go, Tenet Healthcare's Tax Provisions surged by 79285.71% in 2024, and later plummeted by 8093.33% in 2025.
  • Quarter analysis of 5 years shows Tenet Healthcare's Tax Provisions stood at $108.0 million in 2021, then tumbled by 56.48% to $47.0 million in 2022, then skyrocketed by 34.04% to $63.0 million in 2023, then soared by 31.75% to $83.0 million in 2024, then tumbled by 55.42% to $37.0 million in 2025.
  • Its Tax Provisions stands at $37.0 million for Q4 2025, versus $133.0 million for Q3 2025 and $120.0 million for Q2 2025.